EPA

Category
lipid
Routes
Oral (PO)
Half-Life (t½)
PO: 18h
Formula
C20H30O2
Molecular Weight
302.45 g/mol
PubChem CID
446284
Aliases
Eicosapentaenoic acid, C20:5n3

Pharmacological Mechanism

C20:5 ω-3 polyunsaturated fatty acid. Substrate for COX/LOX enzymes generating series-3 (less inflammatory) prostaglandins + thromboxanes + series-5 leukotrienes. Direct modulator of inflammatory gene expression via PPAR-α, FFAR4. Cardiovascular + triglyceride-lowering effects.

Half-Life & Elimination Curve (PO: 18h)

100%50%25%12.5%0%0h0×t½18h1×t½36h2×t½54h3×t½3d4×t½3.8d5×t½0×t½ (0h): 100% remaining1×t½ (18h): 50% remaining2×t½ (36h): 25% remaining3×t½ (54h): 12.5% remaining4×t½ (3d): 6.3% remaining5×t½ (3.8d): 3.1% remaining
Elimination (PO)
  • 0×t½0h100%
  • 1×t½18h50%
  • 2×t½36h25%
  • 3×t½54h12.5%
  • 4×t½3d6.3%
  • 5×t½3.8d3.1%
Elimination t½18h (PO)
Rate Constant (ke)0.0385 h⁻¹
97% Washout (5×t½)3.8d

Dosing Guidelines

Pathways It Modulates

Target Organ Systems

Top Dietary Sources

Chemical Structure & Identifiers